Dyadic International Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
Frequently asked questions
To buy Dyadic International Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Dyadic International Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Dyadic International Inc. is DYAI:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Dyadic International Inc. has its primary listing on NASDAQ (Small cap). You can trade Dyadic International Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Dyadic International Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Dyadic International Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Dyadic International Inc..